|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Robertson JH, Sarkar S, Yang SY, Seifalian
AM and Winslet MC: In vivo models for early development of
colorectal liver metastasis. Int J Exp Pathol. 89:1–12. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alaiyan B, Ilyayev N, Stojadinovic A,
Izadjoo M, Roistacher M, Pavlov V, Tzivin V, Halle D, Pan H, Trink
B, et al: Differential expression of colon cancer associated
transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.
BMC Cancer. 13:1962013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu K, Yao H, Wen Y, Zhao H, Zhou N, Lei S
and Xiong L: Functional role of a long non-coding RNA
LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to
pohotodynamic therapy. Biochim Biophys Acta Mol Basis Dis.
1864:2871–2880. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olthof MR, Hollman PC and Katan MB:
Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr.
131:66–71. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hong J, Lu H, Meng X, Ryu JH, Hara Y and
Yang CS: Stability, cellular uptake, biotransformation, and efflux
of tea polyphenol (−)-epigallocatechin-3-gallate in HT-29 human
colon adenocarcinoma cells. Cancer Res. 62:7241–7246.
2002.PubMed/NCBI
|
|
7
|
Tsukuda K, Tanino M, Soga H, Shimizu N and
Shimizu K: A novel activating mutation of the K-ras gene in human
primary colon adenocarcinoma. Biochem Biophys Res Commun.
278:653–658. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu
F, Peng Z and Yan D: lncRNA-ATB mediated E-cadherin repression
promotes the progression of colon cancer and predicts poor
prognosis. J Gastroenterol Hepatol. 31:595–603. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benson AB, Venook AP, Al-Hawary MM,
Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Engstrom PF, et al: NCCN guidelines insights: Colon cancer, version
2.2018. J Natl Compr Canc Netw. 16:359–369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bernard D, Prasanth KV, Tripathi V,
Colasse S, Nakamura T, Xuan Z, Zhang MQ, Sedel F, Jourdren L,
Coulpier F, et al: A long nuclear-retained non-coding RNA regulates
synaptogenesis by modulating gene expression. EMBO J. 29:3082–3093.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L and Fan Z: lncBRM initiates YAP1
signalling activation to drive self-renewal of liver cancer stem
cells. Nat Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 44:20–27. 2013.
|
|
15
|
Huang JL, Zheng L, Hu YW and Wang Q:
Characteristics of long non-coding RNA and its relation to
hepatocellular carcinoma. Carcinogenesis. 35:507–514. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Timp W and Feinberg AP: Cancer as a
dysregulated epigenome allowing cellular growth advantage at the
expense of the host. Nat Rev Cancer. 13:497–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu D, Yang B, Chen J, Xiong H, Li Y, Pan
Z, Cao Y, Chen J, Li T, Zhou S, et al: Upregulation of long
non-coding RNA RAB1A-2 induces FGF1 expression worsening lung
cancer prognosis. Cancer Lett. 438:116–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smolle MA, Bullock MD, Ling H, Pichler M
and Haybaeck J: Long non-coding RNAs in endometrial carcinoma. Int
J Mol Sci. 16:26463–26472. 2013. View Article : Google Scholar
|
|
20
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang
Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA
MALAT1 suppresses breast cancer metastasis. Nat Genet.
50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang Y, Xiang B, Liu Y, Wang Y and Kan H:
lncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human
hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Cancer
Lett. 437:56–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yao H, Duan M, Lin L, Wu C, Fu X, Wang H,
Guo L, Chen W, Huang L, Liu D, et al: TET2 and MEG3 promoter
methylation is associated with acute myeloid leukemia in a hainan
population. Oncotarget. 8:18337–18347. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo W, Dong Z, Shi Y, Liu S, Liang J, Guo
Y, Guo X, Shen S and Shan B: Aberrant methylation-mediated
downregulation of long noncoding RNA LOC100130476 correlates with
malignant progression of esophageal squamous cell carcinoma. Dig
Liver Dis. 48:961–969. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ranstam J and Cook JA: LASSO regression.
Br J Surg. 105:13482018. View Article : Google Scholar
|
|
26
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Adler P, Kolde R, Kull M, Tkachenko A,
Peterson H, Reimand J and Vilo J: Mining for coexpression across
hundreds of datasets using novel rank aggregation and visualization
methods. Genome Biol. 2009:R1392009. View Article : Google Scholar
|
|
28
|
Xue W, Li J, Wang F, Han P, Liu Y and Cui
B: A long non-coding RNA expression signature to predict survival
of patients with colon adenocarcinoma. Oncotarget. 8:101298–101308.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang WJ, Li HT, Yu JP, Han XP, Xu ZP, Li
YM, Jiao ZY and Liu HB: A competing endogenous RNA network reveals
novel potential lncRNA, miRNA, and mRNA biomarkers in the prognosis
of human colon adenocarcinoma. J Surg Res. 235:22–33. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang JY, Wang CL, Wang XM and Liu FJ:
Comprehensive analysis of microRNA/mRNA signature in colon
adenocarcinoma. Eur Rev Med Pharmacol Sci. 21:2114–2129.
2017.PubMed/NCBI
|
|
31
|
Chen F, Li Z and Zhou H: Identification of
prognostic miRNA biomarkers for predicting overall survival of
colonadenocarcinoma and bioinformatics analysis: A study based on
the cancer genome atlas database. J Cell Biochem. 120:9839–9849.
2019. View Article : Google Scholar : PubMed/NCBI
|
